Jane Street
IMNM icon

Jane Street’s Immunome IMNM Stock Holding History

Jane Street’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Buy
50,500
+14,300
+40% +$318K ﹤0.01% 6277
2025
Q4 		$778K Buy
+36,200
New +$635K ﹤0.01% 6692
2022
Q2 		– Sell
-10,400
Closed -$59K – 10189
2022
Q1 		$59K Hold
10,400
– – ﹤0.01% 9640
2021
Q4 		$135K Buy
+10,400
New +$185K ﹤0.01% 9069

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Jane Street's IMNM Position: Q4 2025 in Review

Jane Street sold out of Immunome (IMNM) in Q4 2025, closing a stake of 60,708 shares — an estimated $1.07M sold.

Jane Street first reported a position in IMNM in Q4 2023 and held it in 6 quarters. The position peaked at $4.88M in Q1 2024. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • Jane Street reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 60,708 Immunome shares in Q4 2025, an estimated $1.07M.
  • Jane Street first reported a position in Immunome in Q4 2023 and held it in 6 quarters.
  • Jane Street's Immunome position peaked at $4.88M in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.